and are jointly administered under Case No. The Company's cases have been assigned to the Honorable James L.
#ENDO INTERNATIONAL LOCATIONS CODE#
On May 31, 2023, Operand Pharmaceuticals II Limited and Operand Pharmaceuticals III Limited each filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York. On May 25, 2023, Operand Pharmaceuticals Holdco II Limited and Operand Pharmaceuticals Holdco III Limited each filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York. Bankruptcy Court for the Southern District of New York. On August 16, 2022, Endo International plc and certain of its subsidiaries (collectively, "Endo" or the "Company") initiated voluntary prearranged Chapter 11 proceedings in the U.S.
Commonwealth of Kentucky, ex rel., Andy Beshear, Attorney General, and All Defendants Identified on Exhibit A to the Complaint) Notice of Sale, Bidding Procedures, Auction, and Sale Hearing for the Sale of Substantially All Assets (the "Sale Notice").Notice of Deadlines for Filing Proofs of Claim (the "Bar Date Notice").Notice of Final Order Establishing Notice and Objection Procedures for Trading in Equity Securities of the Debtors.Notice of Commencement and 341 Meeting of Creditors.Submit Rights Offering Subscription Form.
0 kommentar(er)
